APA (7th ed.) Citation

C, G., GI, P., S, S., L, P., S, D. M., A, M., . . . M, F. (2026). Depression severity and efficacy outcomes: Post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants. International clinical psychopharmacology, 41(4), 213. https://doi.org/10.1097/YIC.0000000000000618

Chicago Style (17th ed.) Citation

C, Guidetti, et al. "Depression Severity and Efficacy Outcomes: Post Hoc Analyses from a Phase 3 Trial of Esmethadone for the Adjunctive Treatment of Major Depressive Disorder with Inadequate Response to Standard Antidepressants." International Clinical Psychopharmacology 41, no. 4 (2026): 213. https://doi.org/10.1097/YIC.0000000000000618.

MLA (9th ed.) Citation

C, Guidetti, et al. "Depression Severity and Efficacy Outcomes: Post Hoc Analyses from a Phase 3 Trial of Esmethadone for the Adjunctive Treatment of Major Depressive Disorder with Inadequate Response to Standard Antidepressants." International Clinical Psychopharmacology, vol. 41, no. 4, 2026, p. 213, https://doi.org/10.1097/YIC.0000000000000618.